Âé¶¹´«Ã½

This website uses cookies to understand how you use the website and to improve your experience. By continuing to use the website, you accept the Âé¶¹´«Ã½â€™s use of cookies and similar technologies. To learn more about our use of cookies and how to manage your browser cookie settings, please review our Privacy Notice.

Todd Vanderah and Ed Bilsky labs publish findings in ‘Life Sciences’ journal

The laboratories of Todd Vanderah, Ph.D., professor of pharmacology in the Center for Excellence in the Neurosciences (CEN), and Edward Bilsky, Ph.D., vice president for research and scholarship, professor of pharmacology, and director of CEN, recently published their research findings in opioid pharmacology and drug development in the scientific journal Life Sciences.

The article, titled "Novel fentanyl-based dual _/_-opioid agonists for the treatment of acute and chronic pain," builds upon Vanderah’s and Bilsky’s previous research on interactions between two different types of opioid receptors named Mu and Delta and how these receptors may cross-talk to produce superior analgesia, or pain relief.